MARKET

CGEN

CGEN

Compugen
NASDAQ
1.600
+0.200
+14.29%
Pre Market: 1.601 +0.001 +0.06% 08:00 05/01 EDT
OPEN
1.450
PREV CLOSE
1.400
HIGH
1.600
LOW
1.420
VOLUME
3
TURNOVER
--
52 WEEK HIGH
2.660
52 WEEK LOW
1.130
MARKET CAP
149.62M
P/E (TTM)
-10.0629
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CGEN last week (0421-0425)?
Weekly Report · 3d ago
Weekly Report: what happened at CGEN last week (0414-0418)?
Weekly Report · 04/21 09:41
Weekly Report: what happened at CGEN last week (0407-0411)?
Weekly Report · 04/14 09:39
Weekly Report: what happened at CGEN last week (0331-0404)?
Weekly Report · 04/07 09:38
Markets Watch Out For Core CPI With Big Banks Set To Report Earnings
Seeking Alpha · 04/05 15:00
Catalyst Watch: Tariff drama, big banks report earnings, Walmart meeting, and the CPI print
Seeking Alpha · 04/04 19:00
BeiGene slips on decision to halt lung cancer program
Seeking Alpha · 04/03 10:58
Weekly Report: what happened at CGEN last week (0324-0328)?
Weekly Report · 03/31 09:42
More
About CGEN
More
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Recently
Symbol
Price
%Change

Webull offers Compugen Ltd (USA) stock information, including NASDAQ: CGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CGEN stock methods without spending real money on the virtual paper trading platform.